insights_auto
Why is PTX down 4.48%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.064
arrow_downward
-4.48%(-0.0030) 1D
Oct 1, 2:35:53 PM GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.22M
Avg. vol.
1.14M
Volume
3.01M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.22M
Avg. vol.
1.14M
Volume
3.01M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
TipRanks
·
1 day ago
Prescient Therapeutics Issues New Class of Long-Dated Unquoted Options
TipRanks
·
1 day ago
Prescient Therapeutics Seeks ASX Quotation for 73.8 Million New Shares
TipRanks
·
1 day ago
Prescient Therapeutics Seeks ASX Quotation for 18.5 Million New Shares
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com